Angelo Delmonte

2PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 21, 2025
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial.

Federico Cappuzzo, Biagio Ricciuti, Angelo Delmonte

|Apr 26, 2024
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study.

Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran

Pageof 1

Frequent Collaborators

1 joint publications

Duncan A Wheatley

1 joint publications

Rossana Berardi

1 joint publications

Miguel A Climent Duran

1 joint publications

Anna Tomiak